Search
for
Sort by
Research 151–180 of 1000+
- Compounding as a Current Therapeutic Option in Dermatology
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- The pharmacology of methotrexate
- Vitamin D and the skin: Focus on a complex relationship: A review
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Oral Retinoids in Dermatology
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Prospective, Open-Label, Multi-Centre, Randomized Study to Compare the Effectiveness, Safety, and Tolerability of Lulican™ Shampoo Versus Ketoconazole Shampoo in Indian Adult Patients With Mild to Moderate Scalp Seborrheic Dermatitis (LEAD Study)
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- SPT6 maintains epidermal homeostasis by inhibiting an NF-κB-positive feedback loop to prevent excessive inflammation
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- The Relationship Between Depression Levels and Suicide Risk in Pediatric Patients with Alopecia Areata and the Oxidant-Antioxidant Balance
- The Itchy Scalp
- Quality of life in patients with seborrheic dermatitis
- Mechanisms regulating skin immunity and inflammation
- Videodermoscopy in the evaluation of hair and scalp disorders
- Association of oxidative stress in mild patchy alopecia areata: a case- control study
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Alopecia areata and vitamin D: Is there any association?
- Aldesleukin
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis
- Impact of Pediatric Alopecia Areata on Quality of Life of Patients and Their Family Members: A Nationwide Multicenter Questionnaire Study
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66‐patient case series and proposal of classification